EGF and malignant colon neoplasm: The epidermal growth factor (EGF), due to its specific and strong binding to the receptor, was successfully used as a functionalization strategy in colon cancer drug delivery [232,233], by exploiting, for example, PLGA nanoparticles [234] or lipid-based systems [235,236].